|
1
|
Schütte K, Bornschein J and Malfertheiner
P: Hepatocellular carcinoma-epidemiological trends and risk
factors. Dig Dis. 27:80–92. 2009. View Article : Google Scholar
|
|
2
|
Lv B, Zhang L, Miao R, Xiang X, Dong S,
Lin T, Li K and Kai Q: Comprehensive analysis and experimental
verification of LINC01314 as a tumor suppressor in hepatoblastoma.
Biomed Pharmacother. 98:783–792. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marin JJG, Briz O, Herraez E, Lozano E,
Asensio M, Di Giacomo S, Romero MR, Osorio-Padilla LM,
Santos-Llamas AI, Serrano MA, et al: Molecular bases of the poor
response of liver cancer to chemotherapy. Clin Res Hepatol
Gastroenterol. 42:182–192. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng Z, Li X and Ding J: Characteristics
of liver cancer stem cells and clinical correlations. Cancer Lett.
379:230–238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Llovet JM and Bruix J: Systematic review
of randomized trials for unresectable hepatocellular carcinoma:
Chemoembolization improves survival. Hepatology. 37:429–442. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen S, Saiyin H, Zeng X, Xi J, Liu X, Li
X and Yu L: Isolation and functional analysis of human HMBOX1, a
homeobox containing protein with transcriptional repressor
activity. Cytogenet Genome Res. 114:131–136. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dai J, Wu L, Zhang C, Zheng X, Tian Z and
Zhang J: Recombinant expression of a novel human transcriptional
repressor HMBOX1 and preparation of anti-HMBOX1 monoclonal
antibody. Cell Mol Immunol. 6:261–268. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Holland PW, Booth HA and Bruford EA:
Classification and nomenclature of all human homeobox genes. BMC
Biol. 5:472007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Su L, Zhao H, Sun C, Zhao B, Zhao J, Zhang
S, Su H and Miao J: The role of Hmbox1 in endothelial
differentiation of bone-marrow stromal cells by a small molecule.
ACS Chem Biol. 5:1035–1043. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma H, Su L, Yue H, Yin X, Zhao J, Zhang S,
Kung H, Xu Z and Miao J: HMBOX1 interacts with MT2A to regulate
autophagy and apoptosis in vascular endothelial cells. Sci Rep.
12:151212015. View Article : Google Scholar
|
|
12
|
Feng X, Luo Z, Jiang S, Li F, Han X, Hu Y,
Wang D, Zhao Y, Ma W, Liu D, et al: The telomere-associated
homeobox-containing protein TAH1/HMBOX1 participates in telomere
maintenance in ALT cells. J Cell Sci. 126:3982–3989. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu L, Zhang C, Zheng X, Tian Z and Zhang
J: HMBOX1, homeobox transcription factor, negatively regulates
interferon-γ production in natural killer cells. Int
Immunopharmacol. 11:1895–1900. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu L, Zhang C and Zhang J: HMBOX1
negatively regulates NK cell functions by suppressing the
NKG2D/DAP10 signaling pathway. Cell Mol Immunol. 8:433–440. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dai J, Zhang C, Tian Z and Zhang J:
Expression profile of HMBOX1, a novel transcription factor, in
human cancers using highly specific monoclonal antibodies. Exp Ther
Med. 2:487–490. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
|
17
|
Hou L, Li Y, Song H, Zhang Z, Sun Y, Zhang
X and Wu K: Protective macroautophagy is involved in vitamin E
succinate effects on human gastric carcinoma cell line SGC-7901 by
inhibiting mTOR axis phosphorylation. PLoS One. 10:e01328292015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang C, Jia X, Wang K, Bao J, Li P, Chen
M, Wan JB, Su H, Mei Z and He C: Polyphyllin VII induces an
autophagic cell death by activation of the JNK pathway and
inhibition of PI3K/AKT/mTOR pathway in HepG2 cells. PLoS One.
11:e01474052016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ghoshal S, Fuchs BC and Tanabe KK: STAT3
is a key transcriptional regulator of cancer stem cell marker CD133
in HCC. Hepatobiliary Surg Nutr. 5:201–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bahnassy AA, Fawzy M, El-Wakil M, Zekri
AR, Abdel-Sayed A and Sheta M: Aberrant expression of cancer stem
cell markers (CD44, CD90, and CD133) contributes to disease
progression and reduced survival in hepatoblastoma patients: 4-year
survival data. Transl Res. 165:396–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Singh U, Quintanilla RH, Grecian S, Gee
KR, Rao MS and Lakshmipathy U: Novel live alkaline phosphatase
substrate for identification of pluripotent stem cells. Stem Cell
Rev. 8:1021–1029. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Li A, Glas M, Lal B, Ying M, Sang Y,
Xia S, Trageser D, Guerrero-Cázares H, Eberhart CG, et al: c-Met
signaling induces a reprogramming network and supports the
glioblastoma stem-like phenotype. Proc Nat Acad Sci USA.
108:9951–9956. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Noguchi K, Eguchi H, Konno M, Kawamoto K,
Nishida N, Koseki J, Wada H, Marubashi S, Nagano H, Doki Y, et al:
Susceptibility of pancreatic cancer stem cells to reprogramming.
Cancer Sci. 106:1182–1187. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kawasaki A, Shinkai Y, Yagita H and
Okumura K: Expression of perforin in murine natural killer cells
and cytotoxic T lymphocytes in vivo. Eur J Immunol. 22:1215–1219.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Subleski JJ, Hall VL, Back TC, Ortaldo JR
and Wiltrout RH: Enhanced antitumor response by divergent
modulation of natural killer and natural killer T cells in the
liver. Cancer Res. 66:11005–11012. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bai X, Wang S, Tomiyama-Miyaji C, Shen J,
Taniguchi T, Izumi N, Li C, Bakir HY, Nagura T, Takahashi S, et al:
Transient appearance of hepatic natural killer cells with high
cytotoxicity and unique phenotype in very young mice. Scand J
Immunol. 63:275–281. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang Y, Han Q, Hou Z, Zhang C, Tian Z and
Zhang J: Exosomes mediate hepatitis B virus (HBV) transmission and
NK-cell dysfunction. Cell Mol Immunol. 14:465–475. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu D, Han Q, Hou Z, Zhang C and Zhang J:
miR-146a negatively regulates NK cell functions via STAT1
signaling. Cell Mol Immunol. 14:712–720. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ishiyama K, Ohdan H, Ohira M, Mitsuta H,
Arihiro K and Asahara T: Difference in cytotoxicity against
hepatocellular carcinoma between liver periphery natural killer
cells in humans. Hepatology. 43:362–372. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sung MW, Johnson JT, Van Dongen G and
Whiteside TL: Protective effects of interferon-gamma on
squamous-cell carcinoma of head and neck targets in
antibody-dependent cellular cytotoxicity mediated by human natural
killer cells. Int J Cancer. 66:393–399. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rautou PE, Mansouri A, Lebrec D, Durand F,
Valla D and Moreau R: Autophagy in liver diseases. J Hepatol.
53:1123–1134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Czaja MJ: Functions of autophagy in
hepatic and pancreatic physiology and disease. Gastroenterology.
140:1895–1908. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kwanten WJ, Martinet W, Michielsen PP and
Francque SM: Role of autophagy in the pathophysiology of
nonalcoholic fatty liver disease: A controversial issue. World J
Gastroenterol. 20:7325–7338. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun K, Guo XL, Zhao QD, Jing YY, Kou XR,
Xie XQ, Zhou Y, Cai N, Gao L, Zhao X, et al: Paradoxical role of
autophagy in the dysplastic and tumor-forming stages of
hepatocarcinoma development in rats. Cell Death Dis. 4:e5012013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou R, Yazdi AS, Menu P and Tschopp J: A
role for mitochondria in NLRP3 inflammasome activation. Nature.
469:221–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nakahira K, Haspel JA, Rathinam VA, Lee
SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim
HP, et al: Autophagy proteins regulate innate immune responses by
inhibiting the release of mitochondrial DNA mediated by the NALP3
inflammasome. Nat Immunol. 12:222–230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Castillo EF, Dekonenko A, Arko-Mensah J,
Mandell MA, Dupont N, Jiang S, Delgado-Vargas M, Timmins GS,
Bhattacharya D, Yang H, et al: Autophagy protects against active
tuberculosis by suppressing bacterial burden and inflammation. Proc
Nat Acad Sci USA. 109:E3168–E3176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jordan CT, Guzman ML and Noble M: Cancer
stem cells. N Engl J Med. 355:1253–1261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Magee JA, Piskounova E and Morrison SJ:
Cancer stem cells: Impact, heterogeneity, and uncertainty. Cancer
Cell. 21:283–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ma S: Biology and clinical implications of
CD133+ liver cancer stem cells. Exp Cell Res.
319:126–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO,
Zheng BJ and Guan XY: Identification and characterization of
tumorigenic liver cancer stem/progenitor cells. Gastroenterology.
132:2542–2556. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rountree CB, Senadheera S, Mato JM, Crooks
GM and Lu SC: Expansion of liver cancer stem cells during aging in
methionine adenosyltransferase 1A-deficientmice. Hepatology.
47:1288–1297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sui Q, Zhang J, Sun X, Zhang C, Han Q and
Tian Z: NK cells are the crucial antitumor mediators when
STAT3-mediated immunosuppression is blocked in hepatocellular
carcinoma. J Immunol. 193:2016–2023. 2014. View Article : Google Scholar : PubMed/NCBI
|
